Times Of India – Surat

Surat to get Rs 90 cr Stem Cell Hospital

SURAT: The city has taken a major leap in medical field. A stem cell hospital to be developed at a cost of Rs 90 crore will become operational within three years.

The entire project will be undertaken and financed by the government health department and Rs 30 crore will be released this year as the first installment.

The 160-bed hospital will also carry out extensive research on stem cell.

The seven-storey building will come up adjacent to the Cancer Research Centre in New Civil Hospital campus. The posts of microbiologist, pathologist, paediatrician and administrator have already been approved and process of recruitments is underway.

“We have already started work for constructing the laboratory. The entire project is going on at a good speed,” said M K Vadel, superintendent of NCH.

San Diego, California-based Global Institute of Stem Cell Therapy and Research will provide the necessary technical assistance, train the local staff and assist in research activity.

“We are working on the design of the project which is the in final stage and once the grant is received we would start the construction work full steam. The project is being developed in Surat keeping the health issues related to tribals,” said Vadel.

Sickle-cell anaemia being a prevalent problem in the tribal belt of south Gujarat, research in using stem cell technology can help in controlling it, experts believe.

“Currently, the hospital will focus largely on sickle-cell anemia and spinal cord problems,” added Vadel.

The NCH authorities are yet to get details about the treatment charges for citizens. The project will be another major development at the Surat NCH after initiation of leptospirorsis laboratory and cancer research.

Source

Osteoarthritis Stem Cell Therapy at Giostar – Patient Testimonial

I reside in Gujarat, and my mother Jeevantika Desai, who is 79 years of age is suffering from osteoarthritis and knee joint problem from the last 15 to 17 years. She has been suggested to go for knee replacement surgery, but she was not ready for that. Fortunately, we came across the details of stem cell procedure conducted at Giostar hospital Ahmedabad. I made some enquiries through email and phone, and I went to Ahmedabad to meet Dr Divyang personally and we had a detailed discussion regarding stem cell therapy and the consequences of this therapy. I was convinced, my mother was admitted on third of September 2014, on fourth the procedure of stem cell treatment was carried out, and she was discharged the next day. Now, after fifteen to sixteen days of the treatment, I am very happy to see recovery of my mother’s problem. The pain has almost gone, there is little bit pain, but it is still very reasonable as compared to what she has been suffering before this procedure was conducted.  The swelling has also reduced and is still reducing tremendously. In fact, I must say that this is a miraculous recovery. Still only fifteen days has passed, but as the protocol is of 45 to 60 days, I think by the end of first 60 days of follow up she will be recovering almost more than 90 percent and after the second follow up of another 60 days, I am sure that she will be recovering from all the pain. I strongly recommended to all those patients who suffer from osteoarthritis and who have been suggested replacement, to go for stem cell treatment conducted at Giostar Hospital Ahmedabad. I personally thank all the team of doctors and all the staff for the cooperation that they offered. My sincere personal regards to Dr Divyang Sir, who is so humble and cooperative and he has been there as for all our clarifications and he has done a great job to my mother. Thank you so much.

Note: Result varies from patient to patient. These testimonials do not constitute typical results nor do we claim otherwise.

GIOSTAR Chairman Dr. Anand Srivastava and GIOSTAR CEO Mr. Deven Patel Meeting at the University of Panama

GIOSTAR was invited by University of Panama’s President office to explore the possibility of establishing the stem cell research program for the country of Panama.  University of Panama being the largest university in the country wanted to develop the stem cell science related curriculum for its medical collage.  GOSTAR being the prominent institute in the filed of stem cell research from USA, would be the perfect match for the country like Panama to step in the arena which requires strong scientific guidance and support.   This much needed collaboration would help the country like Panama to prepare its upcoming researchers to compete in the highly competitive field of stem cell science.

GIOSTAR Chairman Dr. Anand Srivastava interviewed by President office of University of Panama for the collaboration in the field of stem cell science.

GIOSTAR Chairman Dr. Anand Srivastava discussing advancement of stem cell science with the President of University of Panama in Panama City.

GIOSTAR Chairman Dr. Anand Srivastava and GIOSTAR CEO Mr. Deven Patel received by President office of University of Panama for the collaboration efforts to bring the USA based institution in the Panama for the advancement of stem cell science.

University of Panama

University of Panama